Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pella Pharmaceuticals is a Jordan-based pharmaceutical and dermatology-focused manufacturer operating under the Derma Pella brand. The company develops, manufactures, and commercializes topical pharmaceutical, cosmeceutical, and selected medical device products aimed primarily at skin and hair conditions, including acne, pigmentation, anti-aging, moisturization, sun care, and related specialty categories. Its business appears centered on marketed branded and generic dermatologic products rather than a conventional clinical-stage innovative drug pipeline. Pella states that it manages activities from research and development through manufacturing, production, distribution, and after-sales support, and it distributes products across Jordan and multiple international markets. The company also engages in contract manufacturing arrangements and positions itself as a maker of generic dermatological pharmaceuticals and cosmetics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pella Pharmaceuticals.